Meach Cove Capital

The firm is run by three General Partners: Harris Komishane, Ken Zolot, and James Cornell. John Abele, the Boston Scientific co-founder and anchor Limited Partner, provides strategic guidance but the GPs lead deal sourcing and portfolio management. There is no publicly disclosed investment committee beyond the three named GPs.

John Abele owns Meach Cove Farms, a 1,000-acre certified organic farm in Shelburne, Vermont, which operates as a separate commercial entity. The farm's ongoing work — including organic row crops, biomass fuel research, and solar energy — shapes the firm's investment thesis by providing a real-world lens on agricultural innovation, but the farm and the fund are legally distinct.

Yes. The firm's stated focus is investing in entrepreneurs advancing food production, alternative foods, biomaterials, and personalized nutrition. Areas of active investment include cell-cultured foods, precision fermentation, crop-microbiome engineering, and next-generation oils that reduce the carbon footprint of consumer products.

The firm writes early-stage checks, specifically at the seed and start-up phases. It does not publicly disclose a typical check size, but the portfolio composition — computational-biology platforms, bioreactor developers, and alternative-protein companies — is consistent with venture investing that precedes Series A rounds.

No. The firm describes itself as an early-stage venture firm. John Abele serves as the anchor Limited Partner rather than the sole capital source, though the fund does not publicly disclose whether it accepts outside LPs or how concentrated its investor base is beyond Abele.